Abstract:Objective To observe the bioactivity of recombinant human scFv antibody against NH-lipopolysaccharide binding protein in vitro and in vivo. Methods KM mice, weighing 20-25 g, were burnt on the back to the third degree covering 20% total body surface area. The mice in only burn group were intraperitoneally injected with 1 μg/g LPS and those in scFv-treated group with 1 μg/g LPS and 0.5 μg/g scFv after burn. The mice without any treatment served as controls. All mice were sacrificed in 1, 3, 6, 12, 24 h after all treatment and the whole blood, the tissues of liver, lung and kidney were collected. The serum concentration of TNF-α, IL-6 in burnt mice with endotoxemia was detected by ELISA and the pathological changes of liver, lung and kidney tissues were observed by light microscope. The inhibition of scFv antibody of different concentrations against NH-lipopolysaccharide binding protein on FITC-LPS binding with U937 cells was assayed by FCM. Results The histopathological changes of liver, lung and kidney in mice of scFv-treated group revealed that less inflammatory cell infiltration, less degenerated cells, weaker congestion in tissue as compared with control and only burnt mice. The serum concentration of TNF-α in only burnt mice increased significantly than that of the controls (P<0.01 and P<0.05), and the serum level of TNF-α in scFv-treated group in 1 h and 3 h was significantly lower than that of only burnt group (P<0.05). The content of IL-6 in the only burnt mice was significantly higher than that of controls after 3 h (P<0.01 and P<0.05). The IL-6 level of scFv-treated group decreased significantly than that of only burnt group (P<0.01). The fluorescence intensity on U937 cells was weaken after treated by the scFv antibody. Conclusion The recombinant scFv antibody against NH-LBP plays a potential protective role in the endotoxemia. In addition, result also revealed that LBP plays a key role in the pathogesis of LPS.

Preparation and Characterization of Disulfide Stabilized Fv Fragment Antibody Against N-terminal Fragment of Human Lipopolysaccharide Binding Protein

Reconstruction,expression and characterization of dsFv V_L of human antibody to N terminal fragment of human lipopolysaccharide binding protein

Construction and Expression of the Single Chain Fv Antibody Against Human Lipocalin-type Prostaglandin D Synthase

Gene Construction, Expression and Biological Activity Analyses of Disulfide Stabilized Fv Fragment Against Xac

[Construction of Human Phage Antibody Library and Screening and Characterization of Phage Antibodies Against N Terminal Fragment of Human Lipopolysaccharide Binding Protein].

Construction of Single Chain Antibody Library Against Human NH-lipopolysaccharide Binding Protein(NH-LBP) and in Vitro Expression of NH-LBP Antibody

Predicating the Molecular Structure of Single Chain Fragment Variable Antibody Against NH2-terminal Lipopolysaccharide Binding Protein by Bioinformation Technique

Bioactivity of scFv antibody against human NH-lipopolysaccharide binding protein in vitro and in vivo

Prokaryotic expression and antigenicity analysis of N-terminal fragment of human LBP

Expression, Purification and Identification of Human N Terminal Lipopolysaccharide Binding Protein by Insect Sf21 or Sf9 Cells

Screening and identification of phage antibodies against human lipopolysaccharide binding protein

Prokaryotic Expression of Ligand Binding Domain of Porcine Integrin Β8 As FMDV Receptor and Preparation of Its Polyclonal Antibody

Preparation and Identification of Anti-lactoferrin Single Chain Fv Antibody

Study on Subunit Vaccine of Staphylococcus Aureus Fibronectin-Binding Protein A

[Preparation, Epitope Analysis and Clinical Application of Monoclonal Antibodies Against Heart-Type Fatty Acid Binding Protein].

Study on the Inhibition of Hepatitis B Virus by Single-chain Fv Fragment

Expression, Purification of Humanized Truncated LBP in Baculovirus Expression Vector System

Expression of VH-linker-VL Orientation-Dependent Single-Chain Fv Antibody Fragment Derived from Hybridoma 2E6 Against Aflatoxin B1 in Escherichia Coli

Structural and Genetic Basis for the Binding of a Mouse Monoclonal Antibody to Flavobacterium Psychrophilum Lipopolysaccharide

Preparation of Polyclonal Antibodies with Recombinant N Terminus of Porcine Lactotransferrin

Engineering Production of Functional Scfv Antibody in E. Coli by Co-Expressing the Molecule Chaperone Skp